AktieBiotechnologie

Seagen

WKN
A2QFAQ
Ticker
SGEN
SGT
ISIN
US81181C1045

Unternehmens­daten

Stammdaten zu Seagen

WKN
A2QFAQ
ISIN
US81181C1045
Home-Symbol
SGEN
Symbol
SGT
Branche
Biotechnologie
Sektor
Chemie / Pharma / Gesundheit
Unternehmen
Land

Marktdaten

Marktkapitalisierung
Anzahl Aktien
Streubesitz

Mitglieder & Anteilseigner

Anteilseigner

Baker Bros. Advisors LPThe Vanguard Group, Inc.Pentwater Capital Management LPBlackRock Fund AdvisorsPRIMECAP Management Co.SSgA Funds Management, Inc.Millennium Management LLCCitadel Advisors LLCCapital Research & Management Co. (World Investors)Balyasny Asset Management LPNorges Bank Investment ManagementGeode Capital Management LLCCapital Research & Management Co. (International Investors)Avoro Capital Advisor LLCJPMorgan Investment Management, Inc.Barclays Bank Plc (Private Banking)BlackRock Advisors (UK) Ltd.Tudor Investment Corp.TIG Advisors LLCPSquared Asset Management AG
  • Baker Bros. Advisors LP (23,62 %)
  • The Vanguard Group, Inc. (6,89 %)
  • Pentwater Capital Management LP (6,83 %)
  • BlackRock Fund Advisors (4,42 %)
  • PRIMECAP Management Co. (3,32 %)
  • SSgA Funds Management, Inc. (1,78 %)
  • Millennium Management LLC (1,62 %)
  • Citadel Advisors LLC (1,29 %)
  • Capital Research & Management Co. (World Investors) (1,25 %)
  • Balyasny Asset Management LP (1,21 %)
  • Norges Bank Investment Management (1,16 %)
  • Geode Capital Management LLC (1,12 %)
  • Capital Research & Management Co. (International Investors) (0,97 %)
  • Avoro Capital Advisor LLC (0,93 %)
  • JPMorgan Investment Management, Inc. (0,91 %)
  • Barclays Bank Plc (Private Banking) (0,74 %)
  • BlackRock Advisors (UK) Ltd. (0,63 %)
  • Tudor Investment Corp. (0,62 %)
  • TIG Advisors LLC (0,60 %)
  • PSquared Asset Management AG (0,56 %)

Kontakt